MHRA guidance on the use of real-world data in clinical studies to support regulatory decisions
1. Scope This document provides an introduction to the MHRA’s real-world data (RWD) guideline series, and points to consider when evaluating whether a RWD source is of sufficient quality for the intended use. Sponsors interested in the use of RWD in their development programmes are encouraged to engage with the MHRA for further…